(Reuters) - Bristol-Myers Squibb Co and bluebird bio Inc said on Friday their experimental therapy for a type of multiple myeloma met the main goal in a mid-stage study.

MAIDSTONE, England (Reuters) - The leader of Britain's opposition Labour Party leader Jeremy Corbyn said democratic socialism had improved the living standards of the country's poorest in the past and the party would turn to it again if he wins the Dec. 12 election.

(Reuters Health) - People who brush their teeth three times a day are less likely to develop atrial fibrillation or heart failure than those with less consistent oral hygiene habits, a Korean study suggests.

(Reuters Health) - New research throws cold water on a popular exercise recovery regimen, finding that ice baths after a workout may actually impede muscle building.

BARCELONA (Reuters) - Spain's Grifols said on Friday the latest results from a clinical trial of its Alzheimer's treatment show positive effects by achieving a reduction of the disease's progression in patients with mild and moderate conditions.

VICTORIA FALLS, Zambia (Reuters) - For decades Victoria Falls, where southern Africa's Zambezi river cascade down 100 metres into a gash in the earth, have drawn millions of holidaymakers to Zimbabwe and Zambia for their stunning views.

Dec 6 (Reuters) -

(Reuters) - The U.S. Food and Drug Administration on Friday approved Amgen Inc's biosimilar copy of Johnson & Johnson's blockbuster rheumatoid arthritis drug, Remicade, according to the regulator's website.

(Reuters) - Alexion Pharmaceuticals Inc said on Friday its board of directors had unanimously rejected hedge fund Elliott Management's push for a "proactive sale" process of the entire company because it would not be in the best interest of shareholders.